Scott Centea, Sr. VP/GM Angiodynamics

114 posts

Scott Centea, Sr. VP/GM Angiodynamics

Scott Centea, Sr. VP/GM Angiodynamics

@CenteaScott

I love my life, wife, kids and job. I like three day weekends, outdoors and sports. I’m constantly curious.

Saratoga Springs, NY Katılım Haziran 2014
486 Takip Edilen216 Takipçiler
Scott Centea, Sr. VP/GM Angiodynamics
This EXCITING ACHIEVEMENT would not have been possible without the tremendous collaboration of @PERTConsortium , @BrentKeeling & @msran124 , all of the enrolling sites... and of course...our dedicated team members @angiodynamics - THANK YOU
AngioDynamics, Inc.@angiodynamics

We are proud to announce the completion of enrollment for the APEX-AV Study, in collaboration with @PERTConsortium! We'd like to extend our deepest gratitude to each of our study sites for their dedication and contributions to this important study.

English
0
3
12
632
Scott Centea, Sr. VP/GM Angiodynamics retweetledi
AngioDynamics Cardiovascular
AngioDynamics Cardiovascular@AngioDynamicsCV·
We're at #TCT in San Francisco! Be sure you calendar these 2 incredible opportunities to listen from experts in the field on their experience with the #Auryon System. Want to learn more? Stop by booth 236 - we can't wait to meet you.
AngioDynamics Cardiovascular tweet media
English
0
2
0
159
Scott Centea, Sr. VP/GM Angiodynamics retweetledi
AngioDynamics, Inc.
AngioDynamics, Inc.@angiodynamics·
Next week we'll be at #TCT in San Francisco, CA! We are bringing the best of our restorative flow therapy portfolio, including the #AngioVac, #AlphaVac, and the #Auryon Systems. See you there!
English
0
4
4
446
Scott Centea, Sr. VP/GM Angiodynamics
3 years ago we embarked on a journey of innovation and impact with the launch of our @AuryonPad system. Today we’re raising a toast to the remarkable strides we’ve made in transforming care. Here’s to the countless lives improved and the dedicated team behind it all! Thank you.
AngioDynamics Cardiovascular@AngioDynamicsCV

Today marks 3 years since @angiodynamics commercially launched the #Auryon System! Since launch, 35,000+ patients have received treatment with this technology. We are incredibly grateful for all of our partners, care teams, field teams, and clinicals for moving PAD care forward.

English
0
0
6
262
Scott Centea, Sr. VP/GM Angiodynamics
“Oh wow” “Wait, seriously?” “That’s really cool”. “OMG”. “Stop it” These were just a few comments made by our physician partners after learning of what #Auryon can do in Medial Arterial Calcium. Thanks @_backtable and @JRUNMD for sharing in our excitement!
AngioDynamics Cardiovascular@AngioDynamicsCV

Tune in to this week's @_backtable podcast episode to hear Dr. @JRUNMD discuss the recently published MicroCT Study. Curious on how the Auryon System can change the game in below-the-knee medial calcium? Listen here: backtable.com/shows/vi/podca…

English
0
0
4
278
Scott Centea, Sr. VP/GM Angiodynamics
As a new technology, we often measure success through revenue performance and market share gain…but when we step back from those numbers, the ones that matter most become apparent…the lives we help change. #PAD #CLIfighters #Proud
AngioDynamics Cardiovascular@AngioDynamicsCV

Thanks to our partners in healthcare who go above & beyond, over 25,000 patients have been treated since the full commercial launch of the #Auryon System. We are proud to have crossed this milestone in 2022 & we look forward to enhancing treatment options in 2023! #PAD

English
0
2
5
388
Scott Centea, Sr. VP/GM Angiodynamics
@MohammedQintar , Thank you for sharing and for you and your teams continued effort in helping advance care through talented hands and technology. L O V E the “OG” tag as well…perfect! #LargeBoreOG #CardioTwitter
Mohammed Qintar, MD MSc@MohammedQintar

Excited to share our case series on left sided Angiovac @LargeBoreOG mass extraction. This demonstrates the feasibility and safety of such approach and calls for bigger studies to confirm. doi.org/10.1002/ccd.30… @DeeDeeWangMD @PedroMDMSc @BillONeillMD @MarvinEng3 @TiberioFrisoli

English
0
0
2
0
Scott Centea, Sr. VP/GM Angiodynamics
This event signals @angiodynamics commitment to progress #VTE treatment with physician led technology #AlphaVac. The first step in our exciting journey started TOGETHER with @MichaelJolly77 @JoeCampbellMD & @OhioHealth. Sincere thanks & appreciation.
Scott Centea, Sr. VP/GM Angiodynamics tweet media
AngioDynamics, Inc.@angiodynamics

Congratulations to our partners at @OhioHealth @RiversideHosp on the first-in-human case using the AlphaVac F18 System! We are proud to be your partners in patient care. Learn more about the AlphaVac System at alpha-vac.com bit.ly/Angio-risk-info

English
0
2
10
0